Johnson & Johnson Research and Development Expenses 2010-2024 | JNJ

Johnson & Johnson research and development expenses for the twelve months ending December 31, 2024 were $17.232B, a 14.23% increase year-over-year.

  • Johnson & Johnson annual research and development expenses for 2024 were $17.232B, a 14.23% increase from 2023.
  • Johnson & Johnson annual research and development expenses for 2023 were $15.085B, a 6.72% increase from 2022.
  • Johnson & Johnson annual research and development expenses for 2022 were $14.135B, a 0.99% decline from 2021.

Johnson & Johnson Research and Development Expenses 2010-2024 | JNJ

  • Johnson & Johnson annual research and development expenses for 2024 were $17.232B, a 14.23% increase from 2023.
  • Johnson & Johnson annual research and development expenses for 2023 were $15.085B, a 6.72% increase from 2022.
  • Johnson & Johnson annual research and development expenses for 2022 were $14.135B, a 0.99% decline from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$827.9B
Novo Nordisk (NVO)$375.8B
AbbVie (ABBV)$354.6B
Roche Holding AG (RHHBY)$262.5B
Merck (MRK)$221.8B
Novartis AG (NVS)$219.3B
Pfizer (PFE)$146.8B
Sanofi (SNY)$137.4B
Bayer (BAYRY)$22.6B
Innoviva (INVA)$1.1B